Cosciens Biopharma (CSCI) AGM 2024 summary

Opening remarks and agenda

• Meeting opened with introductions of the board and explanation of virtual meeting procedures.

• Attendees were informed about the rules for submitting questions and voting electronically.

• The agenda included financial statement presentation, board elections, auditor appointment, and a special resolution for a corporate name change.

Board and executive committee updates

• Seven individuals were nominated for election to the board, following the resignation of one nominee prior to the meeting.

• All nominees confirmed their willingness to serve and met legal qualifications.

Overview of voting outcomes

• Six of seven director nominees were elected; one nominee, Dennis Turpin, did not receive a majority but will remain temporarily as per regulations.

• Deloitte LLP was reappointed as auditor, with the board authorized to set their remuneration.

• The special resolution to change the company name to COSCIENS Biopharma Inc. was approved.